Dhananjay Chitale

9.7k citations

106 papers · 5.4k indexed · 1 hit paper · h-index 32

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment

Papers in

Cancer Research 41
- Breast Cancer Treatment Studies 19
- Cancer Genomics and Diagnostics 16
Oncology 41
- Colorectal Cancer Treatments and Studies 6

Co-authors: Marc Ladanyi Neal I. Lindeman Philip T. Cagle Erik Thunnissen Sanja Đačić Jeremy A. Squire Giuseppe Giaccone Mary Beth Beasley
Journals: Modern Pathology (8 papers)Cancer Research (7 papers)Clinical Cancer Research (3 papers)Journal of Thoracic Oncology (3 papers)Archives of Pathology & Laboratory Medicine (3 papers)
Partner nations: United States Canada Netherlands

In The Last Decade

Dhananjay Chitale

99 papers receiving 5.3k citations

Hit Papers

align trajectories log scale

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology 2013 · 967 citations

Peers

Countries citing papers authored by Dhananjay Chitale

Since Specialization

Citations

This map shows the geographic impact of Dhananjay Chitale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dhananjay Chitale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dhananjay Chitale more than expected).

Fields of papers citing papers by Dhananjay Chitale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dhananjay Chitale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dhananjay Chitale. The network helps show where Dhananjay Chitale may publish in the future.

Co-authors

The 25 scholars most cited alongside Dhananjay Chitale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dhananjay Chitale Line = papers co-authored together Dhananjay Chitale links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	p16, COX-2, and Ki67 Protein Expression in DCIS and Risk of Ipsilateral Invasive Breast Cancer Cancer Epidemiology Biomarkers & Prevention ·Thomas E. Rohan, И. Тинтин, G.J. Wheeler, Fergus J. Couch, Robert T. Greenlee, Stacey Honda, Azadeh Stark, Vasif Vali, Dhananjay Chitale, Xiaonan Xue, Mindy Ginsberg, Olivier Loudig	2025	0
2	Comparison of fluorescence in situ hybridization and cytology for the accurate detection of malignant biliary strictures, with emphasis on unusual results Journal of the American Society of Cytopathology ·xiwei cui, Michelle Jin, Brian Theisen, C. Wang, Dhananjay Chitale, M. V. Gapanovich, Marissa A. Lopez‐Pier, Karl Aistleitner, Daniel Schultz, Ziying Zhang	2025	0
3	Gastric Perineurioma: A Rare Entity with Molecular Analysis and Literature Review International Journal of Surgical Pathology ·Marike Bormann, Mischa Billing, Dhananjay Chitale, Z. BERÁNKOVÁ‐KSANDROVÁ	2024	1
4	Convolutional Neural Network Quantification of Gleason Pattern 4 and Association With Biochemical Recurrence in Intermediate-Grade Prostate Tumors Modern Pathology ·Yalei Chen, Mitchell Leus, Yu-Fen Shiu, M. Cortez-Valadez, M. Fortmann, Craig Rogers, Oudai Hassan, Dhananjay Chitale, Kanika Arora, Sean R. Williamson, 吕俊峰, Benjamin A. Rybicki, غصاب الصقر, Albert M. Levin	2023	1
5	Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents Modern Pathology ·Sengul Fatma Isil, 刘华鼐, 寛川嶋, 李守淼, Haythem Ali, Daniel Schultz, Dhananjay Chitale	2021	5
6	Clonal evaluation of prostate cancer molecular heterogeneity in biopsy samples by dual immunohistochemistry and dual RNA in situ hybridization Modern Pathology ·崔林华, Shannon Carskadon, Jia Li, Mitchell Leus, Sengul Fatma Isil, James O. Peabody, Hans Stricker, Dhananjay Chitale, Craig Rogers, Mani Menon, Nilesh Gupta, Tarek A. Bismar, Sean R. Williamson, Nallasivam Palanisamy	2020	7
7	A pediatric case of pigmented epithelioid melanocytoma with chromosomal copy number alterations in 15q and 17q and a novel NTRK3‐SCAPER gene fusion Journal of Cutaneous Pathology ·周作梅田, Simón Hernández, 静杜, P. Anderson, Tor Shwayder, Shannon Carskadon, Aleodor A. Andea, Paul W. Harms, Dhananjay Chitale, Nallasivam Palanisamy	2019	8
8	Mutational Landscape of Aggressive Prostate Tumors in African American Men Cancer Research ·Karla Lindquist, Pamela L. Paris, Thomas J. Hoffmann, Niall J. Cardin, Rémi Kazma, Joel Mefford, Jeffrey P. Simko, Vy Ngo, Yalei Chen, Albert M. Levin, Dhananjay Chitale, Brian T. Helfand, William J. Catàlona, Benjamin A. Rybicki, John S. Witte	2016	54
9	The predictive value of increased sentinel lymph node volume in breast cancer Surgical Oncology ·Michael Sirch, S. David Nathanson, Ronnie Chatterji, Dhananjay Chitale, Edward L. Peterson	2016	2
10	The Association amongst ‘Triple Negative’ Breast Cancers, Lymph Node Metastasis, Disease Free and Overall Survival Rupen Shah, Iris Veit, S. David Nathanson, Dhananjay Chitale, Meredith Mahan	2015	1
11	Racial differences in the relationship between clinical prostatitis, presence of inflammation in benign prostate and subsequent risk of prostate cancer Prostate Cancer and Prostatic Diseases ·Benjamin A. Rybicki, Oleksandr N. Kryvenko, Yu Wang, Michelle Jankowski, Sheri Trudeau, Dhananjay Chitale, Hanson Fombalag Fuofu, Andrew Rundle, Deliang Tang	2015	22
12	Array-CGH Shows Amplification of 8q Including <b><i>MYC</i></b> as the Sole Aberration in a Leiomyosarcoma of the Female Lower Genital Tract Cytogenetic and Genome Research ·Nandita Barnabas, Shilpa P. Metkar, Dhananjay Chitale, Adewale Adeyinka	2014	2
13	Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Journal of Molecular Diagnostics ·Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley, Dhananjay Chitale, Sanja Đačić, Giuseppe Giaccone, Robert B. Jenkins, David J. Kwiatkowski, Juan‐Sebastian Saldivar, Jeremy A. Squire, Erik Thunnissen, Marc Ladanyi	2013	367
14	Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African Americans Journal of Thoracic Oncology ·J. Matthew Reinersman, Melissa L. Johnson, Gregory J. Riely, Dhananjay Chitale, Anthony D. Nicastri, Gerald A. Soff, Ann G. Schwartz, Camelia S. Sima, Olga V. Bobrova, Christopher Lau, Maureen F. Zakowski, Valerie W. Rusch, Marc Ladanyi, Mark G. Kris	2010	112
15	Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA , and AKT1 Cancer Research ·Julio C. Ricarte‐Filho, Mabel Ryder, Dhananjay Chitale, Michael Rivera, Adriana Heguy, Marc Ladanyi, Manickam Janakiraman, David B. Solit, Jeffrey A. Knauf, R. Michael Tuttle, Ronald Ghossein, James A. Fagin	2009	420
16	The Henry Ford Production System: LEAN Process Redesign Improves Service in the Molecular Diagnostic Laboratory Journal of Molecular Diagnostics ·Milena Cankovic, Toiba Mushtaq, Ph. D. Marius Hriscu, Eiryann Humbert, С. П. Якупова, Dhananjay Chitale, Richard J. Zarbo	2009	19
17	Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases Clinical Cancer Research ·Julie M. Wu, Mary Jo Fackler, Marc K. Halushka, Żaklina Skrenty, D. Pignatti, Wei Wen Teo, Constance A. Griffin, John H. Fetting, Nancy E. Davidson, Angelo M. De Marzo, Jessica Hicks, Dhananjay Chitale, Marc Ladanyi, Saraswati Sukumar, Pedram Argani	2008	165
18	Genetic Predictors of MEK Dependence in Non–Small Cell Lung Cancer Cancer Research ·Christine A. Pratilas, Aphrothiti J. Hanrahan, Ensar Halilovic, Yogindra Persaud, Junichi Soh, Dhananjay Chitale, Hisayuki Shigematsu, Hiromasa Yamamoto, Ayana Sawai, Manickam Janakiraman, Barry S. Taylor, William Pao, Shinichi Toyooka, Marc Ladanyi, Adi F. Gazdar, Neal Rosen, David B. Solit	2008	195
19	Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma Journal of Thoracic Oncology ·Jenifer L. Marks, Stephen Broderick, Qin Zhou, Dhananjay Chitale, Allan R. Li, Maureen F. Zakowski, Mark G. Kris, Valerie W. Rusch, Christopher G. Azzoli, Venkatraman Seshan, Marc Ladanyi, William Pao	2008	202
20	Expression of cancer–testis antigens in endometrial carcinomas using a tissue microarray Modern Pathology ·Dhananjay Chitale, Achim A. Jungbluth, Alinne Martins Ferreira Marins, Mario M. Leitão, Cyrus V. Hedvat, Denise Kolb, Giulio C. Spagnoli, Kristin Iversen, Robert A. Soslow	2004	29

About Dhananjay Chitale

Dhananjay Chitale is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Rheumatology, having authored 106 papers that have together received 5.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (19 papers), Cancer Genomics and Diagnostics (16 papers), Breast Lesions and Carcinomas (16 papers), Lung Cancer Treatments and Mutations (13 papers), Prostate Cancer Diagnosis and Treatment (12 papers), Epigenetics and DNA Methylation (10 papers), Prostate Cancer Treatment and Research (10 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Cancer Research (2.0k citations), Pulmonary and Respiratory Medicine (2.9k citations), Oncology (2.3k citations), Pathology and Forensic Medicine (660 citations) and Molecular Biology (2.1k citations). Dhananjay Chitale has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Marc Ladanyi, Neal I. Lindeman, Philip T. Cagle, Erik Thunnissen, Sanja Đačić, Jeremy A. Squire, Giuseppe Giaccone, Mary Beth Beasley, David J. Kwiatkowski and Robert B. Jenkins. Their work appears in journals such as Modern Pathology, Cancer Research, Clinical Cancer Research, Journal of Thoracic Oncology and Archives of Pathology & Laboratory Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact